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http://dx.doi.org/10.1016/j.pedneo.2A 4-year-old boy presented with enteroviral infection complicated with atypical hemolytic
uremic syndrome (aHUS). Enterovirus RNA was detected by reverse transcription polymerase
chain reaction (RT-PCR) of both blood and kidney biopsy specimens. A survey of the comple-
ment system did not reveal a specific complement defect. Supportive therapy with blood
components transfusion, plasma therapy, and immunosuppressants was administered,
however, renal function did not recover. The results of this report demonstrate that the
enterovirus is the cause of aHUS.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Hemolytic uremic syndrome (HUS) is a common cause of
acute renal failure in children. The presentations includent of Pediatrics, Mackay
n 2, Chungshan North Road,
.tw (J.-D. Tsai).
an Pediatric Association. Publish
012.10.012microangiopathic hemolytic anemia, thrombocytopenia,
and progressive renal failure. It can be classified according
to the etiology and clinical associations.1 Approximately
10% of HUS cases are classified as atypical HUS (aHUS),
which has a poor prognosis, with death rates of up to 25% in
the acute phase, and 50% of patients requiring ongoing
renal replacement therapy.2 Atypical HUS is a heteroge-
neous disease that is caused by defective complement
regulation in >50% of cases. The association between viral
infections and aHUS has been reported, however, reportsed by Elsevier Taiwan LLC. All rights reserved.
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Viral infections were assumed to be the trigger of aHUS in
patients with underlying complement defects. This report
describes the case of a 4-year-old boy who developed HUS
after clinical presentations of enteroviral infection. Renal
pathology confirmed the diagnosis of HUS, and enterovirus
RNA was identified in the kidney and blood specimens. The
possible pathogenesis of enteroviral infection-induced
aHUS is discussed.236 bp 
E4KB-F/E1-R E4KB-F/E1-R 
P SB N M M P SK N
P: positive control 
SB: blood sample 
SK: kidney biopsy sample
N: negative control 
M: 100 bp marker 
Blood Kidney biopsy
236 bp 
Figure 1 Reverse transcriptionepolymerase chain reaction
of blood and kidney biopsy specimens.2. Case Report
A previously healthy 4-year-old boy developed a sore
throat, oral ulcers, and skin vesicles on his limbs, 9 days
prior to admission. Hand-foot-mouth disease was diagnosed
by his primary physician, and symptomatic medicines were
administered. Jaundice and skin petechiae developed after
2 days, and he was transferred to hospital. During this
period, the patient did not have diarrhea, nor did he exhibit
symptoms of upper respiratory tract infection. None of his
family members exhibited the same symptoms. Anemia,
thrombocytopenia, and acute renal failure were detected
at the hospital. The initial laboratory data revealed
hemoglobin (Hb)Z 6.2 g/dL, plateletZ 46  103/mL, white
blood cell count (WBC) Z 3190/uL, serum urea Z 82 mg/
dL, creatinine Z 1.6 mg/dL, lactic dehydrogenase
(LDH) Z 1662 U/L, and total/direct bilirubin Z 1.7/
0.2 mg/dL. The direct and indirect Coombs tests were both
negative. The urinalysis revealed proteinuria (>300 mg/dL)
and microscopic hematuria, but no pyuria. Fragmented red
blood cells (RBC) were found on peripheral blood (PB)
smear, and HUS was highly suspected. His anemia and
thrombocytopenia progressed after a washed packed RBC
and platelet concentrate transfusion. Impaired renal func-
tion progressed and hypertension developed. Conse-
quently, the patient was transferred to our hospital.
He was afebrile (36.4C) on arrival, and his blood pres-
sure was 160/103 mmHg. A physical examination revealed
petechiae over his face, neck, and anterior chest, and pale
conjunctiva and icteric sclera were found. He also had
hepatomegaly (3 cm below right costal margin (RCM)).
Supportive treatments with antihypertensive drugs
(hydralazine and amlodipine) and diuretics (furosemide)
were initially administered, which stabilized his condition.
The throat bacterial culture and antistreptolysin titers
were negative, as was screening for antinuclear factor,
anti-ds DNA, anti-neutrophil cytoplasmic antibody (ANCA),
and anti-glomerular basement membrane (GBM) anti-
bodies. The complements C3 and C4 were both normal. The
viral culture via the throat and rectum resulted in no
growth after 30 days’ incubation. Because no Escherichia
coli serotype O157:H7, Shigella, or Salmonella was isolated
from the stool specimen, pneumococcal infection was
excluded by negative chest roentgenologic finding, urine
pneumococcal antigen, blood culture, and Thomsen-
Friedenreich antigen. Atypical HUS caused by enterovirus
was highly suspected. A renal biopsy was performed 8 days
after admission. Swelling and hyperplasia of the endothe-
lium of arterioles with narrowing of the lumen were
observed under light microscopy. The glomeruli exhibited
swollen endothelia and were bloodless. Both the renaltubules and interstitium were unremarkable. No glomeruli
were identified in an immunofluorescent study (IgG, IgA,
IgM, C3, C1q, kappa, and lamda). Electron microscopy
revealed the swollen endothelium and a widened sub-
endothelial space. The pathology was consistent with
thrombotic microangiopathy. Furthermore, diagnostic
reverse transcription polymerase chain reaction (RT-PCR)3
was used to detect enterovirus RNA. We extracted the
viral RNA from the blood and renal biopsy samples of the
patient. A 236-bp gene fragment in the second half of the 50
noncoding region (NCR) was amplified through one-step RT-
PCR using 10 mL viral RNA template and two 50 NCR-specific
primers, E4KB-F (AAGGTGYGAAGAGYCTATTGAGCTA) and
E1-R (CACCGGATGGCCAATCCA). The results of RT-PCR were
strongly positive in the renal biopsy sample and weakly
positive in the blood sample (Figure 1). Identification of
enterovirus RNA in the kidney and blood, combined with
the characteristic renal histopathologic finding, established
enterovirus as the cause of HUS. Immune investigation,
including complement C3, factor H (CFH), factor I (CFI),
membrane cofactor protein (MCP), and ADAMTS13 (a dis-
integrin and metalloproteinase with a thrombospondin type
1 motif, member 13; also known as von Willebrand factor-
cleaving protease) revealed normal findings. Plasmaphe-
resis (1.5  plasma volume) was performed according to
the hemolytic indexes (Hb, platelet count, LDH, and frag-
mented RBC on PB smear). Immunosuppressants with
steroid, and rituximab were subsequently administered
(Figure 2). The patient received >40 courses of plasma-
pheresis and subsequent plasma infusion. The hemolytic
process ceased gradually; however, the renal function
continued to deteriorate. The patient was initially placed
on hemodialysis and shifted to peritoneal dialysis for renal
failure. He was discharged, and was under regular outpa-
tient follow-up for end-stage renal disease (ESRD).3. Discussion
More than 50% of aHUS cases are caused by defective
complement regulation. Complement control is provided by
a multilayered system of soluble (e.g., complement factor
H and complement factor I) and membrane-anchored
proteins (e.g., MCP/CD46; thrombomodulin, THBD/CD
141). Mutations in these regulators result in loss of control
Figure 2 Hemoglobin (Hb), platelet (PLT) and creatinine (Cr) concentrations, and treatments during hospitalization.
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tions in complement factor B or C3 result in gain of the
function of this enzyme.4 Among the patients with aHUS,
50% had mutations of the complement regulatory proteins
CFH, MCP, or CFI. In addition, 5e10% of children have factor
H dysfunction caused by anti-factor H antibodies.5 The
remaining 40% of aHUS cases are currently unaccounted for,
thereby necessitating the investigation of additional
susceptibility factors. Our patient had a normal serum C3
level; however, a normal C3 level does not exclude an
underlying complement disorder. Moreover, although our
investigations did not identify abnormalities in CFH, CFI,
MCP, or ADAMTS 13, an underlying complement defect
could not be excluded.
Reported viruses associated with aHUS include human
immunodeficiency virus, Epstein-Barr virus, influenza A,
and parvovirus B19.6 Enterovirus-associated HUS was first
described by Glasgow and Balduzzi in 1965.7 Since then,
>60 patients were reported in seven subsequent studies,
including with Coxsackie virus and ECHO virus.8e14 The
diagnoses of enteroviral infection were mostly based on
serology, viral culture from the throat, rectum and feces,
and viral particle found through electron microscopy in
feces (Table 1). Only two patients exhibited evidence by
isolation of a Coxsackie virus A-like agent8 and detection of
Coxsackie virus B antigen from a kidney biopsy specimen.9
Nine familial cases were reported,8,12e14 however, none
of these reports mentioned the underlying complement
defect. We do not agree with De Petris et al that entero-
viral infections must not be considered a cause of HUS.14
Our patient exhibited symptoms and signs of enteroviral
infection, and other possible etiologies, such as Stx-toxinproducing E. coli, Shigella, and pneumococcal infection
were excluded. HUS was confirmed by clinical presenta-
tions and renal biopsy. Diagnostic RT-PCR, which targeted
a 236-bp gene containing enterovirus RNA using fragment in
the 50 NCR, was used to confirm this virus as the cause of
HUS. The 50 NCR seems to be extremely conserved among
enteroviruses and the primers targeted to the 50 NCR are
pan-reactive with the human enteroviruses. Therefore, the
50 NCR has been used extensively in diagnostic RT-PCR
assays for enterovirus infection. The reported sensitivity
and specificity of RT-PCR using serum for detection of the
enteroviruses range from 81% to 92% and 98% to 100%,
respectively. No reports evaluated the use of RT-PCR using
renal biopsy, but by combining the RT-PCR results from
specimens collected from multiple nonpermissive sites, it
may be possible to improve the ability to establish
enteroviral causality.15 The low sensitivity of the viral
culture for identification of enteroviruses from clinical
specimens (only 35e75%) explained the negative results of
our patient.
The pathogenesis of viral infection-induced aHUS is not
fully understood. Most authors suggested that viral infection
may be the trigger event of aHUS in patients with underlying
genetic predispositions. Direct or cytokine storm-mediated
endothelial injury is also a possible mechanism.6 Evidence
suggests that persistent infection of Coxsackie B virus in
human kidney cells and vascular endothelial cells induces an
increased expression of adhesion molecules, which may
contribute to injury of the endothelial cells and lead to
thrombotic microangiopathy.16 The demonstration of
enteroviral RNA sequence on RT-PCR in the renal tissue
supports a direct viral effect. However, we did not identify
Table 1 Reported cases of hemolytic uremic syndrome associated with enterovirus.
Reference Virus Method Patient
number
Familial
case
Glasgow and Balduzzi7 Coxsackie virus A4 Serology 1 Nil
Ray et al8 Coxsackie virus A and B Serology 7 2
Viral culture from tissue, pharyngeal secretion,
stools and urine
Ray et al9 Coxsackie virus B Serology 2 Nil
Viral culture
Austin and Ray10 Coxsackie virus B Serology 15 Nil
Viral culture from throat and rectum
O’Regan et al11 ECHO virus 22 Serology 8 Nil
Viral culture from stool
Larke et al12 Coxsackie virus A4, B2,
B4 Echo virus 11
Serology 10 4
Culture from pharyngeal secretions and feces
Viral particle on electron microscopy
Vecilla et al13 Coxsackie virus B Viral culture 2 2
De Petris et al14 Non-polio enterovirus Serology 33 1
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assays. Further studies may be required to clarify the exact
mechanism of enterovirus-induced aHUS.
The management of HUS was based on the etiology.
Anemia, thrombocytopenia, acute renal failure, and hyper-
tension require supportive therapy. Dialysis may be neces-
sary. Patientswith aHUS, such as complement factor H or von
Willebrand protease deficiency, benefit from plasma
therapy17; however, plasma therapy is contraindicated for
pneumococcal-HUS. The interval between disease onset and
plasma therapy may be too long in this patient, and the
initial plasma therapy may require higher intensity (only 8
times in 3 weeks).17 Plasma therapy was not arranged
immediately after diagnosis, because the patient exhibited
improvement after the supportive treatments and blood
products transfusion. Subsequently, plasmapheresis was
arranged according to the hemolytic indexes and clinical
conditions of the patient. However, our patient progressed
to ESRD, which may have been caused by the treatment
delay or the destructive nature of the disease, because
50e60% of patients with aHUS progress to ESRD.
In conclusion, our report suggests that enteroviruses
must be considered one of the causes of aHUS. The path-
ogenesis of enterovirus-caused HUS includes direct endo-
thelial injury, or a trigger in patients with underlying
complement dysfunctions. Plasma therapy must be admin-
istered as soon as possible after the diagnosis of aHUS.References
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